πŸ‡ΊπŸ‡Έ FDA
Patent

US 12410225

Modulation of dendritic cell lineages

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 12410225 (Modulation of dendritic cell lineages) held by Orionis Biosciences, Inc expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Orionis Biosciences, Inc
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61K38/00, A61P, A61P35/00